A mediterranean diet is cost-effective in patients with previous myocardial infarction

Journal of Nutrition

Volumn 136, Issue 7, 2006, Pages 1879-1885

  Dalziel, Kim ^a   Segal, Leonie ^a   De Lorgeril, Michel ^b  

^a MONASH UNIVERSITY   (Australia)

^b UFR de Medecine   (France)

Author keywords

Cost effectiveness; Economic analysis; Mediterranean diet; Myocardial infarction; Nutrition

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; NUTRITION; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW;

EID: 33745670398     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.7.1879     Document Type: Article

References (39)

1. World Health Organisation (WHO). Cardiovascular disease (CVD): facts. global strategy on diet, physical activity and health. [Online] [cited March, 2005]. Available from: www.who.int.
2. National Center for Chronic Disease Prevention and Health Promotion (CDC). Preventing heart disease and stroke. [Online] [cited March, 2006]. Available from: www.cdc.gov./nccdphp/bb_heartdisease.
3. de Lorgeril M, Salen P, Martin JL, Monhaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779-85.
4. Elley CR, Kerse N, Arroll B, Robinson E. Effectiveness of counselling patients on physical activity in general practice: cluster randomised controlled trial. BMJ. 2003;326:793-8.
5. Steptoe A, Perkins-Porras L, McKay C, Rink E, Hilton S, Cappuccio FP. Behavioural counselling to increase consumption of fruit and vegetables in low income adults: randomised trial. BMJ. 2003;326:855-61.
6. Eriksson J, Lindström J, Valle T, Aunola S, Hämälä inen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Lauhkonen M, et al. on behalf of the Finnish Diabetes Prevention Study Group. Prevention of type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Diabetologica. 1999;42:793-801.
7. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454-9.
8. Sondergaard E, Moller JE, Egstrup K. Effect of dietary intervention and lipid-lowering treatment on brachial vasoreactivity in patients with ischemic heart disease and hypercholesterolemia. Am Heart J. 2003;145:E19.
9. Singh RB, Dubnov G, Niaz MA, Ghosh S, Singh R, Rastogi SS, Manor O, Pella D, Berry EM. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet. 2002;360:1455-61.
10. de Lorgeril M, Salen P, Martin J-L, Mamelle N, Monjaud I, Touboul P, Delaye J. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol. 1996;28:1103-8.
11. de Lorgeril M, Salen P, Caillat-Vallet E, Hanauer MT, Barthelemy JC, Mamelle N. Control of bias in dietary trial to prevent coronary recurrences: the Lyon diet heart study. Eur J Clin Nutr. 1997;51:116-22.
12. Richardson J. Cost utility analysis: what should be measured? Soc Sci Med. 1994;39:7-21.
13. Pope R. Biases from omitted risk effects in standard gamble utilities. J Health Econ. 2004;23:695-735.
14. Kuntz KM, Tsevat J, Goldman L, Weinstein MC. Cost-effectiveness of routine coronary angiography after acute myocardial infarction. Circulation. 1996;94:957-65.
15. Lee TT, Solomon NA, Heidenreich PA, Oehlert J, Garber AM. Cost-effectiveness of screening for carotid stenosis in asymptomatic persons. Ann Intern Med. 1997;126:337-46.
16. Derdeyn CP, Powers WJ. Cost effectiveness of screening for asymptomatic carotid atherosclerotic disease. Stroke. 1996;27:1944-50.
17. Australian Government Department of Health and Ageing. Medicare Benefits Schedule Book, Nov 2004. Commonwealth of Australia, Canberra.
18. Melbourne University Design and Print Centre (2003) Quote based on eight A4 pages.
19. Coles Myer. Coles Online. www.colesonline.com.au (accessed April, 2005)
20. Australian Institute of Health and Welfare (AIHW) 2005 Australian Hospital Statistics, 2002-3 for public hospitals.
21. Dewey HM, Thrift AG, Mihalopoulos C, Carter R, Macdonell RAL, McNeil JJ, Donnan G. Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2003;34:2502-7.
22. Miller DK, Homan SM. Determining transition probabilities: confusion and suggestions. Med Decis Making. 1994;14:52-8.
23. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. BMJ. 1994;308:81-106.
24. Tanne D, Shotan A, Goldbourt U, Haim M, Boyko V, Adler Y. Mandelzweig L, Behar S, for the Bezafibrate Infarction Prevention Study Group. Severity of angina pectoris and risk of ischemic stroke. Stroke. 2002;33:245-50.
25. Peltonen M, Lundberg V, Huhtasaari F, Asplund K. Marked improvement in survival after acute myocardial infarction in middle-aged men but not women. The Northern Sweden MONICA study 1985-94. J Intern Med. 2000;247:579-87.
26. Heit JA, Silvertein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 1990;159:445-53.
27. Petty GW, Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Survival and recurrence after first cerebral infarction: a population based study in Rochester, Minnesota, 1975 through 1989. Neurology. 1998;50:208-16.
28. Commonwealth Department of Health and Ageing. Guidelines for the pharmaceutical industry on preparation of submissions to the pharmaceutical benefits advisory committee. Sept 2002. Commonwealth of Australia.
29. Trichopoulou A, Costacou T, Barnia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348:2599-608.
30. Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, van Staveren WA. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: The Hale Project. JAMA. 2004;292:1433-39.
31. Collaborating WHO. Centre on Surveillance of Cardiovascular Diseases. Global Cardiovascular infobase: country comparisons [online] [accessed March 2005]. Available from: http://www.cvdinfobase.ca/data.htm.
32. Australian Institute of Health and Welfare (AIHW) National Cardiovascular disease and diabetes database. Deaths from acute myocardial infarction in Australia. 2001 [online] [accessed March 2005] .Available from: http://www.aihw.gov.au/pls/cvd/cvd_death.show_form.
33. de Lorgeril M, Salen P, Martin JL, Monjaud I, Boucher P, Mamell N. Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer. Arch Intern Med. 1998;158:1181-7.
34. Leonhauser IU, Dorandt S, Willmund E, Honsel J. The benefit of the Mediterranean diet - considerations to modify German food patterns. Eur J Nutr. 2004;43: Suppl 1:31-8.
35. de Lorgeril M, Salen P, Paillard F, Laporte F, Boucher P, de Leiris J. Mediterranean diet and the French paradox: two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease. Cardiovasc Res. 2002;54:503-15.
36. Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr. 1995; 61(6, Suppl 1)1402S-6.
37. Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med. 2000;132:769-79.
38. Probstfield JL. How cost-effective are new preventive strategies for cardiovascular disease. Am J Cardiol. 2003;91:22G-7.
39. World Health Organisation. Choosing interventions that are cost effective (WHO-CHOICE) [online] [cited March, 2006]. Available from: http://www.who.int/ choice/costs/CER_levels/en/index.html.